Avistone raises $140m to support drug research and development
Avistone has closed its Series B financing round, raising 1bn yuan ($140m), to support clinical research and development of its drug pipeline.
Avistone has closed its Series B financing round, raising 1bn yuan ($140m), to support clinical research and development of its drug pipeline.
What's Your Reaction?
